Search results
Avidity Up 33% on Rare Muscle Disease Study Results - Arcutis Biotherapeutics (NASDAQ:ARQT), Heron...
Benzinga· 1 day agoAvidity Biosciences RNA announced encouraging initial data from the phase I/II FORTITUDE study...
Study to explore how dogs' spots link to diseases
BBC via AOL· 3 days ago“Studying Dalmatians has the potential to enhance our understanding of human genetics – both our evolution and our susceptibility to diseases," Dr Yates...
Avidity (RNA) Up 33% on Rare Muscle Disease Study Results
Zacks via Yahoo Finance· 2 days agoInitial data from an early-stage study shows that treatment with Avidity's (RNA) experimental...
Only 1 in 20 animal studies results in treatments approved for humans
UPI· 8 hours agoOnly 5% of therapies tested in animals wind up being approved by regulators for human use, according...
Genetic atlas shows gum disease may be caused by immunosuppression of skin cells in the mouth
Medical Xpress· 13 hours agoAside from pain and tooth loss, this disease is also associated with more than 60 systemic diseases,...
Cervical cancer screening rates are dropping. Here's why that's an issue.
Yahoo Life Style via AOL· 12 hours agoA new study finds that cervical cancer screenings have dropped. (Getty Images) SDI Productions via...
Climate change linked to increased risk of heart disease worldwide
United Press International via Yahoo News· 1 day agoFor example, the risk of death from heart disease remained elevated up to a year after Hurricane...
Study Elucidates Skin Signs of VEXAS Syndrome
Medscape· 22 hours agoSkin manifestations are common in the vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome and present early in the disease course....
Plant-based ultraprocessed foods linked to heart disease, early death, study says
WKOW 27 Madison· 4 days agoKingdom. “Many foods that do not contain animal products, which includes biscuits, crisps,...
The Zacks Analyst Blog Highlights Biogen, Eli Lilly's, Prothena and AC Immune (Revised)
Zacks via Yahoo Finance· 12 hours agoCassava Sciences is conducting a phase III program consisting of two global studies of simufilam in...